Type 2 biomarkers associated with dupilumab efficacy in patients with uncontrolled, moderate-to-severe asthma enrolled in the phase 3 study LIBERTY ASTHMA QUEST by Wenzel, SE, Pavord, I, Zhang, B, Maroni, J, Rowe, P, Hamilton, JD, Swanson, BN, Amin, N, Pirozzi, G, Graham, NM, Teper, A